Codes / ICD10CM / T51.94XS

T51.94XS Toxic effect of unspecified alcohol, undetermined, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of unspecified alcohol, undetermined, sequela
  • ICD Code: T51.94XS

Summary

This condition represents the residual or chronic effects resulting from a previous toxic exposure to unspecified alcohol, where the intent of exposure was undetermined. It is used to document long-term consequences of alcohol toxicity when the specific type of alcohol and the circumstances of exposure are not clearly identified. Sequela refers to the late effects that persist after the acute phase of the toxic event.

Causes

The sequela arises from a prior toxic effect of unspecified alcohol, where the exact source and intent of exposure were not documented. This may include residual damage from ingestion, inhalation, or absorption of alcohol-containing substances, with the undetermined intent indicating ambiguity about whether the exposure was accidental, intentional, or otherwise unclear.

Risk Factors

  • History of prior alcohol toxicity with unspecified source or intent
  • Underlying organ damage from the initial toxic event (e.g., liver, neurological)
  • Delayed recognition or treatment of the acute exposure
  • Pre-existing conditions that may exacerbate residual effects (e.g., metabolic disorders)

Symptoms

  • Persistent neurological deficits (e.g., cognitive impairment, memory loss)
  • Chronic gastrointestinal issues (e.g., liver dysfunction, abdominal pain)
  • Ongoing respiratory or cardiovascular complications
  • Fatigue or reduced functional capacity
  • Psychological effects such as anxiety or mood changes

Diagnosis

Diagnosis is based on clinical evaluation of residual symptoms, patient history of a prior toxic alcohol exposure, and exclusion of other causes. Documentation must link the current condition to the sequela of the unspecified alcohol toxicity, with evidence of persistent effects beyond the acute phase.

Treatment Options

Management focuses on addressing residual symptoms and preventing further complications. This may include supportive care, rehabilitation for neurological deficits, monitoring of organ function, and lifestyle modifications to reduce stress on affected systems. Treatment is tailored to the specific sequelae present.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial toxicity and the extent of residual damage. Regular follow-up is essential to monitor for worsening symptoms, adjust treatments, and address any new complications. Long-term outcomes vary based on the organs involved and the effectiveness of management.

Complications

  • Progressive organ dysfunction (e.g., liver cirrhosis, chronic kidney disease)
  • Persistent neurological impairment
  • Increased risk of future toxic exposures
  • Psychological or social challenges related to chronic health issues

Lifestyle & Prevention

  • Avoidance of alcohol-containing products to prevent re-exposure
  • Adherence to prescribed monitoring and treatment plans
  • Lifestyle modifications to support organ health (e.g., balanced diet, limited alcohol use)
  • Education on recognizing early signs of recurrence or complications

When to Seek Professional Help

Seek medical attention if new or worsening symptoms occur, such as increased pain, confusion, or difficulty breathing. Prompt evaluation is necessary to address acute exacerbations or new complications related to the sequela.

Tips for Medical Coders

Document the sequela clearly, linking it to the prior toxic effect of unspecified alcohol with undetermined intent. Ensure the code T51.94XS is used only when the condition is a residual effect of the acute toxicity. Include details about the nature of the sequela (e.g., neurological, hepatic) to support coding accuracy.

Book a walkthrough

T51.94XS policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.